HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edgewell’s Q4 Reflects Ongoing Men’s Shave Challenges, REACH Sun-Care Reformulation

This article was originally published in The Rose Sheet

Executive Summary

Despite positive impacts from its Hydro 5 Sense and Intuition f.a.b. razor launches, Edgewell’s global Wet Shave business declined in the fourth quarter and full fiscal 2018. The firm remains focused on slashing costs, an effort that wasn’t helped by a Q4 charge related to REACH ingredient substitution.

Advertisement

Related Content

Cruelty Free International’s China Entry Pilot Enrolls Edgewell’s Bulldog, Neal’s Yard Remedies
P&G Grooming Quits Counting Blades, Innovates In New Directions While Battling DTC Disruptors
Rep. Pallone Keeps After Cosmetics; Edgewell Acquires Jack Black; Coty On Amazon Echo; News In Brief
Cosmetic Launch News: L'Oreal/David Beckham's HOUSE 99; Forever Flawless' Diamond-Infused Mask; More
ECHA Announces Coming Enforcement Projects On REACH Compliance

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS122515

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel